Cargando…
Acetylcarnitine Is Associated With Cardiovascular Disease Risk in Type 2 Diabetes Mellitus
OBJECTIVE: This study aimed to identify the association between specific short-chain acylcarnitines and cardiovascular disease (CVD) in type 2 diabetes mellitus (T2DM). METHOD: We retrieved 1,032 consecutive patients with T2DM who meet the inclusion and exclusion criteria from the same tertiary care...
Autores principales: | Zhao, Shuo, Liu, Ming-Li, Huang, Bing, Zhao, Fu-Rong, Li, Ying, Cui, Xue-Ting, Lin, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712495/ https://www.ncbi.nlm.nih.gov/pubmed/34970228 http://dx.doi.org/10.3389/fendo.2021.806819 |
Ejemplares similares
-
Non-coding RNAs in diabetes mellitus and diabetic cardiovascular disease
por: Li, Chengshun, et al.
Publicado: (2022) -
The Association Between Acylcarnitine Metabolites and Cardiovascular Disease in Chinese Patients With Type 2 Diabetes Mellitus
por: Zhao, Shuo, et al.
Publicado: (2020) -
Anthropometric Measures and Incident Diabetic Nephropathy in Participants With Type 2 Diabetes Mellitus
por: Hukportie, Daniel Nyarko, et al.
Publicado: (2021) -
Nomogram Prediction for the Risk of Diabetic Foot in Patients With Type 2 Diabetes Mellitus
por: Wang, Jie, et al.
Publicado: (2022) -
Dissecting the Association of Apolipoprotein E Gene Polymorphisms With Type 2 Diabetes Mellitus and Coronary Artery Disease
por: Wu, Lei, et al.
Publicado: (2022)